GENSCRIPT BIO_Providing professional financial news and data related to GENSCRIPT BIO, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

GENSCRIPT BIO(01548.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of USD 129.34 million, loss widened by 407.98% YoY

Tags：

GENSCRIPT BIO 01548.HK NewTimeSpace

2026-08-17

GENSCRIPT BIO(01548.HK): Legend Biotech Reports Positive Proof-of-Concept Clinical Data for In-vivo CD19/CD20 Dual-Target CAR-T Therapy LB2501

Tags：

GENSCRIPT BIO 01548.HK Clinical Data

2026-06-14

ETF
Global X China Biotech ETF (02820.HK) Rises 1.37% in Morning Trade, Latest NAV at HKD 74.146
ETF
Csop Samsung Electronics Daily (2x) Leveraged Product (07747.HK) Rises 2.41% in Morning Trade, Turnover at HKD 346 Million
ETF
CSOP SK Hynix Daily (2x) Leveraged Product (07709.HK) Rises 6.93% in Morning Trade, Latest NAV at HKD 37.232
ETF
Global X China Semiconductor ETF (03191.HK) Rises 4.03% in Morning Trade, AUM at HKD 3.547 Billion
ETF
Premia China STAR50 ETF (03151.HK) Rises 2.88% in Morning Trade, Turnover at HKD 3.3823 Million
ETF
Chinaamc CSI 300 Index ETF (03188.HK) Rises 1.54% in Morning Trade, Latest Price at HKD 56.680
Finance
JIANGSU NEW VISION AUTOMOTIVE ELECTRONICS (02632.HK): Expected First-Half Pretax Loss of Approximately RMB 402 Million to 422 Million
Finance
China Ruyi (00136.HK): Expected First-Half Net Profit of Approximately RMB 800 Million to 900 Million
Finance
SenseTime-W (00020.HK): Expected First-Half Profit of Approximately RMB 500 Million to 700 Million
Finance
CanSino Biologics (06185.HK): NDA for Td5cp, a Diphtheria-Tetanus-Pertussis Vaccine for Adolescents and Adults, Accepted for Review

Scan QR Code

Download App